Načítá se...
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Migraine is a very disabling disorder with severe impact on patients’ lives and substantive costs to society in terms of healthcare costs and lost productivity. Prevention is a key component of migraine therapy, and while numerous preventive options exist, each is burdened by either troublesome side...
Uloženo v:
| Vydáno v: | Curr Treat Options Neurol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer US
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5486583/ https://ncbi.nlm.nih.gov/pubmed/28653227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11940-017-0463-4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|